Tag: CMS guidance

Medicare Part B spent $1.5B on COVID-19 tests in 2020

Medicare Part B spending on laboratory tests ticked up to $8 billion in 2020, driven largely by new COVID-19 diagnostics reimbursements, even while spending on other types of tests declined, according to a new report released by the U.S. Department of Health and Human Services’ Office of the Inspector General. In total, there was $1.5 […]
Learn More

Request a Free Quote